{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:16:50Z","timestamp":1775841410473,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG051086"],"award-info":[{"award-number":["R01AG051086"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG010133"],"award-info":[{"award-number":["P30AG010133"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Indiana Alzheimer&apos;s Disease Center Indiana Clinical and Translational Sciences Institute"},{"DOI":"10.13039\/501100001844","name":"DST | National Science and Technology Management Information System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Memory loss is one of the most tragic symptoms of Alzheimer\u2019s disease. Our laboratory has recently demonstrated that \u2018i-Extract\u2019 of Ashwagandha (<jats:italic>Withania somnifera<\/jats:italic>) restores memory loss in scopolamine (SC)-induced mice. The prime target of i-Extract is obscure. We hypothesize that i-Extract may primarily target muscarinic subtype acetylcholine receptors that regulate memory processes. The present study elucidates key target(s) of i-Extract via cellular, biochemical, and molecular techniques in a relevant amnesia mouse model and primary hippocampal neuronal cultures. Wild type Swiss albino mice were fed i-Extract, and hippocampal cells from na\u00efve mice were treated with i-Extract, followed by muscarinic antagonist (dicyclomine) and agonist (pilocarpine) treatments. We measured dendritic formation and growth by immunocytochemistry, kallikrein 8 (KLK8) mRNA by reverse transcription polymerase chain reaction (RT-PCR), and levels of KLK8 and microtubule-associated protein 2, c isoform (MAP2c) proteins by western blotting. We performed muscarinic receptor radioligand binding. i-Extract stimulated an increase in dendrite growth markers, KLK8 and MAP2. Scopolamine-mediated reduction was significantly reversed by i-Extract in mouse cerebral cortex and hippocampus. Our study identified muscarinic receptor as a key target of i-Extract, providing mechanistic evidence for its clinical application in neurodegenerative cognitive disorders.<\/jats:p>","DOI":"10.1038\/s41598-019-48238-6","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T10:04:48Z","timestamp":1569837888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera"],"prefix":"10.1038","volume":"9","author":[{"given":"Arpita","family":"Konar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2364-9649","authenticated-orcid":false,"given":"Bryan","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-5933","authenticated-orcid":false,"given":"Debomoy K.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra K.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"48238_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","unstructured":"Alzheimer\u2019s Association. 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 14, 367\u2013429, https:\/\/doi.org\/10.1016\/j.jalz.2018.02.001 (2018).","journal-title":"Alzheimers Dement."},{"key":"48238_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s1474-4422(16)00065-x","volume":"15","author":"B Maloney","year":"2016","unstructured":"Maloney, B. & Lahiri, D. K. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol. 15, 760\u2013774, https:\/\/doi.org\/10.1016\/s1474-4422(16)00065-x (2016).","journal-title":"Lancet Neurol."},{"key":"48238_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608, https:\/\/doi.org\/10.15252\/emmm.201606210 (2016).","journal-title":"EMBO Mol. Med."},{"key":"48238_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack, C. R. et al. Update on hypothetical model of Alzheimer\u2019s disease biomarkers. Lancet Neurol. 12, 207\u2013216, https:\/\/doi.org\/10.1016\/S1474-4422(12)70291-0 (2013).","journal-title":"Lancet Neurol."},{"key":"48238_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71, 505\u2013508, https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847 (2014).","journal-title":"JAMA Neurol"},{"key":"48238_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12035-008-8018-z","volume":"37","author":"M Knobloch","year":"2008","unstructured":"Knobloch, M. & Mansuy, I. M. Dendritic spine loss and synaptic alterations in Alzheimer\u2019s disease. Mol. Neurobiol. 37, 73\u201382, https:\/\/doi.org\/10.1007\/s12035-008-8018-z (2008).","journal-title":"Mol. Neurobiol."},{"key":"48238_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.200108057","volume":"156","author":"K Stamer","year":"2002","unstructured":"Stamer, K., Vogel, R., Thies, E., Mandelkow, E. & Mandelkow, E. M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051\u20131063, https:\/\/doi.org\/10.1083\/jcb.200108057 (2002).","journal-title":"J. Cell Biol."},{"key":"48238_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0165-3806(95)00083-P","volume":"88","author":"HJ Clarris","year":"1995","unstructured":"Clarris, H. J., Key, B., Beyreuther, K., Masters, C. L. & Small, D. H. Expression of the amyloid protein precursor of Alzheimer\u2019s disease in the developing rat olfactory system. Brain Res. Dev. Brain Res. 88, 87\u201395 (1995).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"48238_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2174\/156720501108140910121631","volume":"11","author":"SJ Wakefield","year":"2014","unstructured":"Wakefield, S. J., McGeown, W. J., Shanks, M. F. & Venneri, A. Differentiating normal from pathological brain ageing using standard neuropsychological tests. Curr Alzheimer Res 11, 765\u2013772 (2014).","journal-title":"Curr Alzheimer Res"},{"issue":"10","key":"48238_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/cns.12395","volume":"21","author":"Yu Sun","year":"2015","unstructured":"Sun, Y., Yang, F. C., Lin, C. P. & Han, Y. Biochemical and Neuroimaging Studies in Subjective Cognitive Decline: Progress and Perspectives. CNS Neurosci. Ther, https:\/\/doi.org\/10.1111\/cns.12395 (2015).","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"17","key":"48238_CR11","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"Hiroki Sasaguri","year":"2017","unstructured":"Sasaguri, H. et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J., https:\/\/doi.org\/10.15252\/embj.201797397 (2017).","journal-title":"The EMBO Journal"},{"key":"48238_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.nicl.2017.06.009","volume":"15","author":"A Kuhla","year":"2017","unstructured":"Kuhla, A. et al. APPswe\/PS1dE9 mice with cortical amyloid pathology show a reduced NAA\/Cr ratio without apparent brain atrophy: A MRS and MRI study. NeuroImage. Clinical 15, 581\u2013586, https:\/\/doi.org\/10.1016\/j.nicl.2017.06.009 (2017).","journal-title":"NeuroImage. Clinical"},{"key":"48238_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.brainresbull.2016.10.002","volume":"127","author":"S Haider","year":"2016","unstructured":"Haider, S., Tabassum, S. & Perveen, T. Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: A comparative study. Brain Res. Bull. 127, 234\u2013247, https:\/\/doi.org\/10.1016\/j.brainresbull.2016.10.002 (2016).","journal-title":"Brain Res. Bull."},{"key":"48238_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","volume":"34","author":"I Klinkenberg","year":"2010","unstructured":"Klinkenberg, I. & Blokland, A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 34, 1307\u20131350, https:\/\/doi.org\/10.1016\/j.neubiorev.2010.04.001 (2010).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"48238_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuint.2015.09.001","volume":"95","author":"R Wadhwa","year":"2016","unstructured":"Wadhwa, R., Konar, A. & Kaul, S. C. Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts. Neurochem. Int. 95, 109\u2013118, https:\/\/doi.org\/10.1016\/j.neuint.2015.09.001 (2016).","journal-title":"Neurochem. Int."},{"key":"48238_CR16","doi-asserted-by":"publisher","first-page":"e27265","DOI":"10.1371\/journal.pone.0027265","volume":"6","author":"A Konar","year":"2011","unstructured":"Konar, A. et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 6, e27265, https:\/\/doi.org\/10.1371\/journal.pone.0027265 (2011).","journal-title":"PLoS One"},{"key":"48238_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5483\/BMBRep.2017.50.1.131","volume":"50","author":"JH Kweon","year":"2017","unstructured":"Kweon, J. H., Kim, S. & Lee, S. B. The cellular basis of dendrite pathology in neurodegenerative diseases. BMB reports 50, 5\u201311 (2017).","journal-title":"BMB reports"},{"key":"48238_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-pathol-012615-044216","volume":"11","author":"J Herms","year":"2016","unstructured":"Herms, J. & Dorostkar, M. M. Dendritic Spine Pathology in Neurodegenerative Diseases. Annu. Rev. Pathol. 11, 221\u2013250, https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044216 (2016).","journal-title":"Annu. Rev. Pathol."},{"key":"48238_CR19","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1097\/00001756-200108280-00031","volume":"12","author":"C Shimizu-Okabe","year":"2001","unstructured":"Shimizu-Okabe, C. et al. Expression of the kallikrein gene family in normal and Alzheimer\u2019s disease brain. Neuroreport 12, 2747\u20132751 (2001).","journal-title":"Neuroreport"},{"key":"48238_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s12035-014-8780-z","volume":"51","author":"A Konar","year":"2015","unstructured":"Konar, A. & Thakur, M. K. Neuropsin Expression Correlates with Dendritic Marker MAP2c Level in Different Brain Regions of Aging Mice. Mol. Neurobiol. 51, 1130\u20131138, https:\/\/doi.org\/10.1007\/s12035-014-8780-z (2015).","journal-title":"Mol. Neurobiol."},{"key":"48238_CR21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1242\/jcs.115.7.1523","volume":"115","author":"D Belanger","year":"2002","unstructured":"Belanger, D. et al. The projection domain of MAP2b regulates microtubule protrusion and process formation in Sf9 cells. J. Cell Sci. 115, 1523\u20131539 (2002).","journal-title":"J. Cell Sci."},{"issue":"3","key":"48238_CR22","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s12035-016-9792-7","volume":"54","author":"Kavita Shah","year":"2016","unstructured":"Shah, K. & Lahiri, D. K. A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5. Mol. Neurobiol., https:\/\/doi.org\/10.1007\/s12035-016-9792-7 (2016).","journal-title":"Molecular Neurobiology"},{"key":"48238_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bpc.2015.06.003","volume":"205","author":"G Mitra","year":"2015","unstructured":"Mitra, G., Gupta, S., Poddar, A. & Bhattacharyya, B. MAP2c prevents arachidonic acid-induced fibril formation of tau: Role of chaperone activity and phosphorylation. Biophys. Chem. 205, 16\u201323, https:\/\/doi.org\/10.1016\/j.bpc.2015.06.003 (2015).","journal-title":"Biophys. Chem."},{"key":"48238_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jnc.13228","volume":"135","author":"C Xie","year":"2015","unstructured":"Xie, C. et al. Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau. J. Neurochem. 135, 19\u201326, https:\/\/doi.org\/10.1111\/jnc.13228 (2015).","journal-title":"J. Neurochem."},{"key":"48238_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.24326","volume":"77","author":"KL Rasmussen","year":"2015","unstructured":"Rasmussen, K. L., Tybjaerg-Hansen, A., Nordestgaard, B. G. & Frikke-Schmidt, R. Plasma levels of apolipoprotein E and risk of dementia in the general population. Ann. Neurol. 77, 301\u2013311, https:\/\/doi.org\/10.1002\/ana.24326 (2015).","journal-title":"Ann. Neurol."},{"key":"48238_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ageing\/afu183","volume":"44","author":"AL Jefferson","year":"2015","unstructured":"Jefferson, A. L., Beiser, A. S., Seshadri, S., Wolf, P. A. & Au, R. APOE and mild cognitive impairment: the Framingham Heart Study. Age Ageing 44, 307\u2013311, https:\/\/doi.org\/10.1093\/ageing\/afu183 (2015).","journal-title":"Age Ageing"},{"key":"48238_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1212\/WNL.0000000000001231","volume":"84","author":"LG Apostolova","year":"2015","unstructured":"Apostolova, L. G. et al. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology 84, 729\u2013737, https:\/\/doi.org\/10.1212\/WNL.0000000000001231 (2015).","journal-title":"Neurology"},{"key":"48238_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1212\/WNL.50.3.669","volume":"50","author":"MR Farlow","year":"1998","unstructured":"Farlow, M. R. et al. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer\u2019s disease. Neurology 50, 669\u2013677 (1998).","journal-title":"Neurology"},{"key":"48238_CR29","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","volume":"92","author":"J Poirier","year":"1995","unstructured":"Poirier, J. et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 12260\u201312264 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48238_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0304-3940(94)90204-6","volume":"182","author":"DY Huang","year":"1994","unstructured":"Huang, D. Y. et al. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease. Neurosci. Lett. 182, 55\u201358 (1994).","journal-title":"Neurosci. Lett."},{"key":"48238_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","volume":"67","author":"B Li","year":"2008","unstructured":"Li, B. et al. Failure of neuronal maturation in Alzheimer disease dentate gyrus. J. Neuropathol. Exp. Neurol. 67, 78\u201384, https:\/\/doi.org\/10.1097\/nen.0b013e318160c5db (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"48238_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jchemneu.2011.05.014","volume":"42","author":"S Shiosaka","year":"2011","unstructured":"Shiosaka, S. & Ishikawa, Y. Neuropsin\u2013a possible modulator of synaptic plasticity. J. Chem. Neuroanat. 42, 24\u201329, https:\/\/doi.org\/10.1016\/j.jchemneu.2011.05.014 (2011).","journal-title":"J. Chem. Neuroanat."},{"key":"48238_CR33","doi-asserted-by":"publisher","first-page":"Kc01","DOI":"10.7860\/jcdr\/2017\/23602.10066","volume":"11","author":"J Sunitha","year":"2017","unstructured":"Sunitha, J. et al. Antimicrobial Effect of Leaves of Phyllanthus niruri and Solanum nigrum on Caries Causing Bacteria: An In vitro Study. Journal of clinical and diagnostic research: JCDR 11, Kc01\u2013kc04, https:\/\/doi.org\/10.7860\/jcdr\/2017\/23602.10066 (2017).","journal-title":"Journal of clinical and diagnostic research: JCDR"},{"key":"48238_CR34","first-page":"10","volume":"1","author":"P Bansal","year":"2017","unstructured":"Bansal, P., Malik, M. A., Das, S. N. & Kaur, J. Tinospora Cordifolia Induces Cell Cycle Arrest in Human Oral Squamous Cell Carcinoma Cells. The Gulf journal of oncology 1, 10\u201314 (2017).","journal-title":"The Gulf journal of oncology"},{"key":"48238_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/sj.bjp.0706122","volume":"144","author":"T Kuboyama","year":"2005","unstructured":"Kuboyama, T., Tohda, C. & Komatsu, K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br. J. Pharmacol. 144, 961\u2013971, https:\/\/doi.org\/10.1038\/sj.bjp.0706122 (2005).","journal-title":"Br. J. Pharmacol."},{"key":"48238_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10522-008-9185-z","volume":"9","author":"RH Singh","year":"2008","unstructured":"Singh, R. H., Narsimhamurthy, K. & Singh, G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology 9, 369\u2013374, https:\/\/doi.org\/10.1007\/s10522-008-9185-z (2008).","journal-title":"Biogerontology"},{"key":"48238_CR37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.pnpbp.2007.09.011","volume":"32","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni, S. K. & Dhir, A. Withania somnifera: an Indian ginseng. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1093\u20131105, https:\/\/doi.org\/10.1016\/j.pnpbp.2007.09.011 (2008).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"48238_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jep.2009.08.003","volume":"125","author":"S RajaSankar","year":"2009","unstructured":"RajaSankar, S. et al. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J. Ethnopharmacol. 125, 369\u2013373, https:\/\/doi.org\/10.1016\/j.jep.2009.08.003 (2009).","journal-title":"J. Ethnopharmacol."},{"key":"48238_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nlm.2013.08.009","volume":"106","author":"A Gautam","year":"2013","unstructured":"Gautam, A., Wadhwa, R. & Thakur, M. K. Involvement of hippocampal Arc in amnesia and its recovery by alcoholic extract of Ashwagandha leaves. Neurobiol. Learn. Mem. 106, 177\u2013184, https:\/\/doi.org\/10.1016\/j.nlm.2013.08.009 (2013).","journal-title":"Neurobiol. Learn. Mem."},{"key":"48238_CR40","doi-asserted-by":"publisher","first-page":"11194","DOI":"10.1523\/jneurosci.2338-05.2005","volume":"25","author":"T Shinoe","year":"2005","unstructured":"Shinoe, T., Matsui, M., Taketo, M. M. & Manabe, T. Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J. Neurosci. 25, 11194\u201311200, https:\/\/doi.org\/10.1523\/jneurosci.2338-05.2005 (2005).","journal-title":"J. Neurosci."},{"key":"48238_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1113\/jphysiol.2004.076539","volume":"562","author":"SR Cobb","year":"2005","unstructured":"Cobb, S. R. & Davies, C. H. Cholinergic modulation of hippocampal cells and circuits. J. Physiol. 562, 81\u201388, https:\/\/doi.org\/10.1113\/jphysiol.2004.076539 (2005).","journal-title":"J. Physiol."},{"key":"48238_CR42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1089\/neu.2008.0671","volume":"25","author":"CD Cox","year":"2008","unstructured":"Cox, C. D. et al. Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury. J. Neurotrauma 25, 1355\u20131365, https:\/\/doi.org\/10.1089\/neu.2008.0671 (2008).","journal-title":"J. Neurotrauma"},{"key":"48238_CR43","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.brainresbull.2008.02.003","volume":"76","author":"B Esmaeili","year":"2008","unstructured":"Esmaeili, B., Basseda, Z. & Dehpour, A. R. Antagonism of muscarinic M1 receptors by dicyclomine inhibits the consolidation of morphine-associated contextual memory. Brain Res. Bull. 76, 380\u2013387, https:\/\/doi.org\/10.1016\/j.brainresbull.2008.02.003 (2008).","journal-title":"Brain Res. Bull."},{"key":"48238_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/cns.12187","volume":"20","author":"PP Tan","year":"2014","unstructured":"Tan, P. P. et al. Activation of muscarinic receptors protects against retinal neurons damage and optic nerve degeneration in vitro and in vivo models. CNS Neurosci. Ther. 20, 227\u2013236, https:\/\/doi.org\/10.1111\/cns.12187 (2014).","journal-title":"CNS Neurosci. Ther."},{"key":"48238_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molbrainres.2003.11.017","volume":"121","author":"I Teber","year":"2004","unstructured":"Teber, I., Kohling, R., Speckmann, E. J., Barnekow, A. & Kremerskothen, J. Muscarinic acetylcholine receptor stimulation induces expression of the activity-regulated cytoskeleton-associated gene (ARC). Brain Res. Mol. Brain Res. 121, 131\u2013136, https:\/\/doi.org\/10.1016\/j.molbrainres.2003.11.017 (2004).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"48238_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejphar.2004.01.022","volume":"487","author":"S Ma","year":"2004","unstructured":"Ma, S., Story, M. E. & Pennefather, J. N. Muscarinic receptors mediating contraction of female mouse urinary bladder: effects of oestrogen. Eur. J. Pharmacol. 487, 205\u2013211, https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.022 (2004).","journal-title":"Eur. J. Pharmacol."},{"key":"48238_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1254\/jphs.10016FP","volume":"112","author":"KS Lee","year":"2010","unstructured":"Lee, K. S. et al. Assessment of novel muscarinic acetylcholine receptors in rat cerebral cortex by a tissue segment binding method. J. Pharmacol. Sci. 112, 444\u2013451 (2010).","journal-title":"J. Pharmacol. Sci."},{"key":"48238_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0650-3","volume":"13","author":"M Gupta","year":"2016","unstructured":"Gupta, M. & Kaur, G. Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study. J. Neuroinflammation 13, 193, https:\/\/doi.org\/10.1186\/s12974-016-0650-3 (2016).","journal-title":"J. Neuroinflammation"},{"key":"48238_CR49","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/gerona\/glp088","volume":"64","author":"N Widodo","year":"2009","unstructured":"Widodo, N. et al. Deceleration of senescence in normal human fibroblasts by withanone extracted from ashwagandha leaves. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1031\u20131038, https:\/\/doi.org\/10.1093\/gerona\/glp088 (2009).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"48238_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cyto.2017.10.019","volume":"102","author":"A Pandey","year":"2018","unstructured":"Pandey, A. et al. Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine 102, 211\u2013221, https:\/\/doi.org\/10.1016\/j.cyto.2017.10.019 (2018).","journal-title":"Cytokine"},{"key":"48238_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jbiotec.2013.08.028","volume":"168","author":"VP Wadegaonkar","year":"2013","unstructured":"Wadegaonkar, V. P. & Wadegaonkar, P. A. Withanone as an inhibitor of survivin: a potential drug candidate for cancer therapy. J. Biotechnol. 168, 229\u2013233, https:\/\/doi.org\/10.1016\/j.jbiotec.2013.08.028 (2013).","journal-title":"J. Biotechnol."},{"key":"48238_CR52","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1158\/1535-7163.mct-14-0324","volume":"13","author":"R Gao","year":"2014","unstructured":"Gao, R. et al. Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K. Mol. Cancer Ther. 13, 2930\u20132940, https:\/\/doi.org\/10.1158\/1535-7163.mct-14-0324 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"48238_CR53","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1158\/1078-0432.ccr-06-0948","volume":"13","author":"N Widodo","year":"2007","unstructured":"Widodo, N. et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin. Cancer Res. 13, 2298\u20132306, https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-0948 (2007).","journal-title":"Clin. Cancer Res."},{"key":"48238_CR54","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1007\/s12035-016-0044-7","volume":"54","author":"NJ Dar","year":"2017","unstructured":"Dar, N. J. et al. Withanone, an Active Constituent from Withania somnifera, Affords Protection Against NMDA-Induced Excitotoxicity in Neuron-Like Cells. Mol. Neurobiol. 54, 5061\u20135073, https:\/\/doi.org\/10.1007\/s12035-016-0044-7 (2017).","journal-title":"Mol. Neurobiol."},{"key":"48238_CR55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/jad-2010-101374","volume":"23","author":"B Ray","year":"2011","unstructured":"Ray, B., Bisht, S., Maitra, A., Maitra, A. & Lahiri, D. K. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell culture and animal model: implications for Alzheimer\u2019s disease. J. Alzheimers Dis. 23, 61\u201377, https:\/\/doi.org\/10.3233\/jad-2010-101374 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"48238_CR56","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1517\/14728222.2010.525352","volume":"14","author":"S Bandyopadhyay","year":"2010","unstructured":"Bandyopadhyay, S., Huang, X., Lahiri, D. K. & Rogers, J. T. Novel drug targets based on metallobiology of Alzheimer\u2019s disease. Expert Opin. Ther. Targets 14, 1177\u20131197, https:\/\/doi.org\/10.1517\/14728222.2010.525352 (2010).","journal-title":"Expert Opin. Ther. Targets"},{"key":"48238_CR57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1471-4159.2010.07145.x","volume":"117","author":"B Ray","year":"2011","unstructured":"Ray, B., Chauhan, N. B. & Lahiri, D. K. Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model. J. Neurochem. 117, 388\u2013402, https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07145.x (2011).","journal-title":"J. Neurochem."},{"key":"48238_CR58","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal, N. et al. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA 109, 3510\u20133515, https:\/\/doi.org\/10.1073\/pnas.1112209109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48238_CR59","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s11064-012-0810-5","volume":"37","author":"S Soman","year":"2012","unstructured":"Soman, S., Korah, P. K., Jayanarayanan, S., Mathew, J. & Paulose, C. S. Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A. Neurochem. Res. 37, 1915\u20131927, https:\/\/doi.org\/10.1007\/s11064-012-0810-5 (2012).","journal-title":"Neurochem. Res."},{"key":"48238_CR60","doi-asserted-by":"publisher","first-page":"e77624","DOI":"10.1371\/journal.pone.0077624","volume":"8","author":"KR Kurapati","year":"2013","unstructured":"Kurapati, K. R., Atluri, V. S., Samikkannu, T. & Nair, M. P. Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8, e77624, https:\/\/doi.org\/10.1371\/journal.pone.0077624 (2013).","journal-title":"PLoS One"},{"key":"48238_CR61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jep.2012.10.063","volume":"145","author":"I Baitharu","year":"2013","unstructured":"Baitharu, I. et al. Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. J. Ethnopharmacol. 145, 431\u2013441, https:\/\/doi.org\/10.1016\/j.jep.2012.10.063 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"48238_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1142\/s0192415x13500365","volume":"41","author":"JP Bhattarai","year":"2013","unstructured":"Bhattarai, J. P., Park, S. J. & Han, S. K. Potentiation of NMDA receptors by Withania somnifera on hippocampal CA1 pyramidal neurons. Am. J. Chin. Med. 41, 503\u2013513, https:\/\/doi.org\/10.1142\/s0192415x13500365 (2013).","journal-title":"Am. J. Chin. Med."},{"key":"48238_CR63","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1248\/bpb.b14-00022","volume":"37","author":"T Kuboyama","year":"2014","unstructured":"Kuboyama, T., Tohda, C. & Komatsu, K. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol. Pharm. Bull. 37, 892\u2013897 (2014).","journal-title":"Biol. Pharm. Bull."},{"key":"48238_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-neuro-062012-170433","volume":"36","author":"A Thiele","year":"2013","unstructured":"Thiele, A. Muscarinic signaling in the brain. Annu. Rev. Neurosci. 36, 271\u2013294, https:\/\/doi.org\/10.1146\/annurev-neuro-062012-170433 (2013).","journal-title":"Annu. Rev. Neurosci."},{"key":"48238_CR65","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","volume":"49","author":"A Caccamo","year":"2006","unstructured":"Caccamo, A. et al. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671\u2013682, https:\/\/doi.org\/10.1016\/j.neuron.2006.01.020 (2006).","journal-title":"Neuron"},{"key":"48238_CR66","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/j.1530-0277.2009.01032.x","volume":"33","author":"KL VanDemark","year":"2009","unstructured":"VanDemark, K. L., Guizzetti, M., Giordano, G. & Costa, L. G. Ethanol inhibits muscarinic receptor-induced axonal growth in rat hippocampal neurons. Alcohol. Clin. Exp. Res. 33, 1945\u20131955, https:\/\/doi.org\/10.1111\/j.1530-0277.2009.01032.x (2009).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"48238_CR67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neuroscience.2006.06.035","volume":"142","author":"S Kotani","year":"2006","unstructured":"Kotani, S., Yamauchi, T., Teramoto, T. & Ogura, H. Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 142, 505\u2013514, https:\/\/doi.org\/10.1016\/j.neuroscience.2006.06.035 (2006).","journal-title":"Neuroscience"},{"key":"48238_CR68","doi-asserted-by":"publisher","first-page":"14538","DOI":"10.1074\/jbc.273.23.14538","volume":"273","author":"H von der Kammer","year":"1998","unstructured":"von der Kammer, H. et al. Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors. J. Biol. Chem. 273, 14538\u201314544 (1998).","journal-title":"J. Biol. Chem."},{"key":"48238_CR69","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/mp.2016.111","volume":"21","author":"N Bartolotti","year":"2016","unstructured":"Bartolotti, N., Bennett, D. A. & Lazarov, O. Reduced pCREB in Alzheimer\u2019s disease prefrontal cortex is reflected in peripheral blood mononuclear cells. Mol. Psychiatry 21, 1158\u20131166, https:\/\/doi.org\/10.1038\/mp.2016.111 (2016).","journal-title":"Mol. Psychiatry"},{"key":"48238_CR70","doi-asserted-by":"publisher","first-page":"17380","DOI":"10.18632\/oncotarget.8041","volume":"7","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling. Oncotarget 7, 17380\u201317392, https:\/\/doi.org\/10.18632\/oncotarget.8041 (2016).","journal-title":"Oncotarget"},{"key":"48238_CR71","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","volume":"148","author":"P Abrams","year":"2006","unstructured":"Abrams, P. et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br. J. Pharmacol. 148, 565\u2013578, https:\/\/doi.org\/10.1038\/sj.bjp.0706780 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"48238_CR72","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1152\/jn.00686.2010","volume":"105","author":"S Dasari","year":"2011","unstructured":"Dasari, S. & Gulledge, A. T. M1 and M4 receptors modulate hippocampal pyramidal neurons. J. Neurophysiol. 105, 779\u2013792, https:\/\/doi.org\/10.1152\/jn.00686.2010 (2011).","journal-title":"J. Neurophysiol."},{"key":"48238_CR73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1101\/lm.34900","volume":"7","author":"RV Fornari","year":"2000","unstructured":"Fornari, R. V., Moreira, K. M. & Oliveira, M. G. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn. Mem. 7, 287\u2013292 (2000).","journal-title":"Learn. Mem."},{"key":"48238_CR74","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0896-6273(02)00641-4","volume":"34","author":"P Delmas","year":"2002","unstructured":"Delmas, P., Wanaverbecq, N., Abogadie, F. C., Mistry, M. & Brown, D. A. Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons. Neuron 34, 209\u2013220 (2002).","journal-title":"Neuron"},{"key":"48238_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2004.02.029","volume":"26","author":"MA Rossi","year":"2005","unstructured":"Rossi, M. A., Mash, D. C. & deToledo-Morrell, L. Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor. Neurobiol. Aging 26, 53\u201368, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.02.029 (2005).","journal-title":"Neurobiol. Aging"},{"key":"48238_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.mcn.2012.03.010","volume":"50","author":"GH Poplawski","year":"2012","unstructured":"Poplawski, G. H. et al. L1CAM increases MAP2 expression via the MAPK pathway to promote neurite outgrowth. Mol. Cell. Neurosci. 50, 169\u2013178, https:\/\/doi.org\/10.1016\/j.mcn.2012.03.010 (2012).","journal-title":"Mol. Cell. Neurosci."},{"key":"48238_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27640-6","volume":"8","author":"A Konar","year":"2018","unstructured":"Konar, A., Kumar, A., Maloney, B., Lahiri, D. K. & Thakur, M. K. A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling. Sci. Rep. 8, 9928, https:\/\/doi.org\/10.1038\/s41598-018-27640-6 (2018).","journal-title":"Sci. Rep."},{"key":"48238_CR78","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/bpa.12599","volume":"28","author":"K Keyvani","year":"2018","unstructured":"Keyvani, K. et al. Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer\u2019s disease. Brain Pathol. 28, 947\u2013964, https:\/\/doi.org\/10.1111\/bpa.12599 (2018).","journal-title":"Brain Pathol."},{"key":"48238_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.05.006","author":"A Herring","year":"2016","unstructured":"Herring, A. et al. Kallikrein-8 inhibition attenuates Alzheimer\u2019s pathology in mice. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2016.05.006 (2016).","journal-title":"Alzheimers Dement."},{"key":"48238_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuint.2017.12.002","volume":"119","author":"H Tamura","year":"2018","unstructured":"Tamura, H., Shiosaka, S. & Morikawa, S. Trophic modulation of gamma oscillations: The key role of processing protease for Neuregulin-1 and BDNF precursors. Neurochem. Int. 119, 2\u201310, https:\/\/doi.org\/10.1016\/j.neuint.2017.12.002 (2018).","journal-title":"Neurochem. Int."},{"key":"48238_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.20","volume":"7","author":"M Kawata","year":"2017","unstructured":"Kawata, M., Morikawa, S., Shiosaka, S. & Tamura, H. Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation. Transl Psychiatry 7, e1052, https:\/\/doi.org\/10.1038\/tp.2017.20 (2017).","journal-title":"Transl Psychiatry"},{"key":"48238_CR82","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1042\/cs20160671","volume":"131","author":"M Kerr","year":"2017","unstructured":"Kerr, M., Dodd, M. S. & Heather, L. C. The \u2018Goldilocks zone\u2019 of fatty acid metabolism; to ensure that the relationship with cardiac function is just right. Clin. Sci. (Lond.) 131, 2079\u20132094, https:\/\/doi.org\/10.1042\/cs20160671 (2017).","journal-title":"Clin. Sci. (Lond.)"},{"key":"48238_CR83","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/neuonc\/nox046","volume":"19","author":"SA Grossman","year":"2017","unstructured":"Grossman, S. A. & Kleinberg, L. A search for the \u201cGoldilocks zone\u201d with regard to the optimal duration of adjuvant temozolomide in patients with glioblastoma. Neuro Oncol. 19, 1019\u20131020, https:\/\/doi.org\/10.1093\/neuonc\/nox046 (2017).","journal-title":"Neuro Oncol."},{"key":"48238_CR84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/ndt.s55104","volume":"10","author":"DJ Foster","year":"2014","unstructured":"Foster, D. J., Choi, D. L., Conn, P. J. & Rook, J. M. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer\u2019s disease and schizophrenia. Neuropsychiatr. Dis. Treat. 10, 183\u2013191, https:\/\/doi.org\/10.2147\/ndt.s55104 (2014).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"48238_CR85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean 3rd","year":"2017","unstructured":"Dean, D. C. 3rd et al. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease. JAMA Neurol 74, 41\u201349, https:\/\/doi.org\/10.1001\/jamaneurol.2016.3232 (2017).","journal-title":"JAMA Neurol"},{"key":"48238_CR86","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2174\/1567205011666141001120903","volume":"11","author":"GA Marshall","year":"2014","unstructured":"Marshall, G. A. et al. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res 11, 853\u2013861 (2014).","journal-title":"Curr Alzheimer Res"},{"key":"48238_CR87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s1474-4422(13)70276-x","volume":"13","author":"R Yan","year":"2014","unstructured":"Yan, R. & Vassar, R. Targeting the beta secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol. 13, 319\u2013329, https:\/\/doi.org\/10.1016\/s1474-4422(13)70276-x (2014).","journal-title":"Lancet Neurol."},{"key":"48238_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.arr.2014.10.003","volume":"20","author":"M Yannakoulia","year":"2015","unstructured":"Yannakoulia, M., Kontogianni, M. & Scarmeas, N. Cognitive health and Mediterranean diet: just diet or lifestyle pattern? Ageing research reviews 20, 74\u201378, https:\/\/doi.org\/10.1016\/j.arr.2014.10.003 (2015).","journal-title":"Ageing research reviews"},{"key":"48238_CR89","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","volume":"11","author":"M Baumgart","year":"2015","unstructured":"Baumgart, M. et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement. 11, 718\u2013726, https:\/\/doi.org\/10.1016\/j.jalz.2015.05.016 (2015).","journal-title":"Alzheimers Dement."},{"issue":"Suppl 2","key":"48238_CR90","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.neurobiolaging.2014.02.031","volume":"35","author":"R Squitti","year":"2014","unstructured":"Squitti, R., Siotto, M. & Polimanti, R. Low-copper diet as a preventive strategy for Alzheimer\u2019s disease. Neurobiol. Aging 35(Suppl 2), S40\u201350, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.02.031 (2014).","journal-title":"Neurobiol. Aging"},{"key":"48238_CR91","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.psc.2014.09.001","volume":"37","author":"S Chiu","year":"2014","unstructured":"Chiu, S. et al. The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer\u2019s disease. Psychiatr. Clin. North Am. 37, 591\u2013623, https:\/\/doi.org\/10.1016\/j.psc.2014.09.001 (2014).","journal-title":"Psychiatr. Clin. North Am."},{"key":"48238_CR92","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/bs.pmbts.2015.07.019","volume":"135","author":"H Pareja-Galeano","year":"2015","unstructured":"Pareja-Galeano, H., Garatachea, N. & Lucia, A. Exercise as a Polypill for Chronic Diseases. Prog. Mol. Biol. Transl. Sci. 135, 497\u2013526, https:\/\/doi.org\/10.1016\/bs.pmbts.2015.07.019 (2015).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"48238_CR93","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1212\/WNL.0000000000000964","volume":"83","author":"OC Okonkwo","year":"2014","unstructured":"Okonkwo, O. C. et al. Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology 83, 1753\u20131760, https:\/\/doi.org\/10.1212\/WNL.0000000000000964 (2014).","journal-title":"Neurology"},{"key":"48238_CR94","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.arr.2011.05.002","volume":"10","author":"P Kaliman","year":"2011","unstructured":"Kaliman, P. et al. Neurophysiological and epigenetic effects of physical exercise on the aging process. Ageing research reviews 10, 475\u2013486, https:\/\/doi.org\/10.1016\/j.arr.2011.05.002 (2011).","journal-title":"Ageing research reviews"},{"key":"48238_CR95","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.exger.2010.01.001","volume":"45","author":"DK Lahiri","year":"2010","unstructured":"Lahiri, D. K. & Maloney, B. The \u201cLEARn\u201d (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer\u2019s disease, and proposes remedial steps. Exp. Gerontol. 45, 291\u2013296, https:\/\/doi.org\/10.1016\/j.exger.2010.01.001 (2010).","journal-title":"Exp. Gerontol."},{"key":"48238_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-18365-7_1","volume":"863","author":"S Rigacci","year":"2015","unstructured":"Rigacci, S. Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer\u2019s Disease. Adv. Exp. Med. Biol. 863, 1\u201320, https:\/\/doi.org\/10.1007\/978-3-319-18365-7_1 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"48238_CR97","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JAD-132231","volume":"41","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Cocoa extracts reduce oligomerization of amyloid-beta: implications for cognitive improvement in Alzheimer\u2019s disease. J. Alzheimers Dis. 41, 643\u2013650, https:\/\/doi.org\/10.3233\/JAD-132231 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"48238_CR98","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/b978-0-7020-4087-0.00061-9","volume":"120","author":"EH Reynolds","year":"2014","unstructured":"Reynolds, E. H. The neurology of folic acid deficiency. Handb. Clin. Neurol. 120, 927\u2013943, https:\/\/doi.org\/10.1016\/b978-0-7020-4087-0.00061-9 (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"48238_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-13-118","volume":"13","author":"H Kim","year":"2014","unstructured":"Kim, H., Kim, G., Jang, W., Kim, S. Y. & Chang, N. Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment. Nutrition journal 13, 118, https:\/\/doi.org\/10.1186\/1475-2891-13-118 (2014).","journal-title":"Nutrition journal"},{"key":"48238_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., Maechler, M. M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Software 67, 1\u201348, https:\/\/doi.org\/10.18637\/jss.v067.i01 (2015).","journal-title":"J. Stat. Software"},{"key":"48238_CR101","unstructured":"Lenth, R. emmeans: Estimated marginal means, aka least-squares means. R package version 1.1.3, https:\/\/CRAN.R-project.org\/package=emmeans (2018)."},{"key":"48238_CR102","unstructured":"R Core Team. R: A language and Environment for Statistical Computing, https:\/\/www.R-project.org (2015)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48238-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:00:29Z","timestamp":1671285629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48238-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48238"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48238-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K.L. is a member of the advisory boards for Entia Biosciences, Drug Discovery and Therapy World Congress, and Provaidya L.L.C. He also has stock options from Q.R. Pharma for patents or patents pending on AIT-082, Memantine, Acamprosate, and GILZ analogues. D.K.L. also had prior funding from Baxter and Forest Research Labs. The authors declare no other actual or potential competing interests in the subject matter of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13990"}}